These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19712811)

  • 1. Angle between 1 and 4 min gives the most significant difference in time-intensity curves between benign disease and breast cancer: analysis of dynamic magnetic resonance imaging in 103 patients with breast lesions.
    Hara M; Watanabe T; Okumura A; Kato K; Mohri N; Ishikawa M; Mizuno A; Takeyama H
    Clin Imaging; 2009; 33(5):335-42. PubMed ID: 19712811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values.
    Peters NH; Vincken KL; van den Bosch MA; Luijten PR; Mali WP; Bartels LW
    J Magn Reson Imaging; 2010 May; 31(5):1100-5. PubMed ID: 20432344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical shift MRI: is there any contribution to morphologic evaluation of solid breast masses?
    Gokalp G; Topal U; Bolca N; Ercan I
    Acad Radiol; 2009 Oct; 16(10):1263-71. PubMed ID: 19608436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions?
    Ballesio L; Savelli S; Angeletti M; Porfiri LM; D'Ambrosio I; Maggi C; Castro ED; Bennati P; Fanelli GP; Vestri AR; Manganaro L
    Eur J Radiol; 2009 Jul; 71(1):96-101. PubMed ID: 18479866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of three different software systems in the evaluation of dynamic MRI of the breast.
    Kurz KD; Steinhaus D; Klar V; Cohnen M; Wittsack HJ; Saleh A; Mödder U; Blondin D
    Eur J Radiol; 2009 Feb; 69(2):300-7. PubMed ID: 18060715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distinguishing benign and malignant lesions with time-signal intensity curve of dynamic contrast-enhanced breast MRI scanning].
    Yuan HM; Yu JQ; Chu ZG; Peng LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):556-9. PubMed ID: 21866648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
    Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
    Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New spatiotemporal features for improved discrimination of benign and malignant lesions in dynamic contrast-enhanced-magnetic resonance imaging of the breast.
    Gal Y; Mehnert A; Bradley A; Kennedy D; Crozier S
    J Comput Assist Tomogr; 2011; 35(5):645-52. PubMed ID: 21926864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis?
    Baltzer PA; Renz DM; Kullnig PE; Gajda M; Camara O; Kaiser WA
    Acad Radiol; 2009 Apr; 16(4):435-42. PubMed ID: 19268855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.
    Fujii S; Kakite S; Nishihara K; Kanasaki Y; Harada T; Kigawa J; Kaminou T; Ogawa T
    J Magn Reson Imaging; 2008 Nov; 28(5):1149-56. PubMed ID: 18972356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of suspicious nipple discharge by magnetic resonance mammography based on breast imaging reporting and data system magnetic resonance imaging descriptors.
    Tokuda Y; Kuriyama K; Nakamoto A; Choi S; Yutani K; Kunitomi Y; Haneda T; Kawai M; Masuda N; Takeda M; Nakamura H
    J Comput Assist Tomogr; 2009; 33(1):58-62. PubMed ID: 19188786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels.
    Fournier LS; Vanel D; Athanasiou A; Gatzemeier W; Masuykov IV; Padhani AR; Dromain C; Galetti K; Sigal R; Costa A; Balleyguier C
    Eur J Radiol; 2009 Jan; 69(1):43-9. PubMed ID: 18829193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
    Yuan Y; Kuai XP; Chen XS; Tao XF
    Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors.
    Eida S; Sumi M; Nakamura T
    J Magn Reson Imaging; 2010 Mar; 31(3):673-9. PubMed ID: 20187211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of breast cancer types by texture analysis of magnetic resonance images.
    Holli K; Lääperi AL; Harrison L; Luukkaala T; Toivonen T; Ryymin P; Dastidar P; Soimakallio S; Eskola H
    Acad Radiol; 2010 Feb; 17(2):135-41. PubMed ID: 19945302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of benign phyllodes tumors of the breast.
    Kinoshita T; Fukutomi T; Kubochi K
    Breast J; 2004; 10(3):232-6. PubMed ID: 15125750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.